HIGHLIGHTS
- who: Yu Xu from the Department of Hematology, First Affiliated Hospital，Zhejiang University School of Medicine, Hangzhou, China have published the article: Real-world data on efficacy and safety of azacitidine therapy in chronic myelomonocytic leukemia in China: results from a multicenter, retrospective study, in the Journal: (JOURNAL)
- how: Given the limited data on AZA treatment in China the authors conducted this retrospective observational study to evaluate the efficacy and safety of AZA response to the treatment of CMML from multiple sites in China. This study was conducted in accordance with the ethical standards of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.